The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global STD Diagnostics Market Research Report 2025

Global STD Diagnostics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1972868

No of Pages : 109

Ask Your Query
Synopsis
STD Diagnostics is the procedure to test if the patient have the STD.
The global STD Diagnostics market was valued at US$ 184080 million in 2023 and is anticipated to reach US$ 296290 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for STD Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding STD Diagnostics.
Report Scope
The STD Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global STD Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the STD Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
ADI/American Diagnostica
Agilent Technologies
Alere/Biosite/Inverness
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Decode Genetics
Diadexus
Diagnocure
Diagnostica Stago/Trinity Biotech
Diamedix
Polymedco
Qiagen
Roche
SDIX
Sequenom
Siemens
Sienco
Sysmex
Takara Bio
ThermoFisher
Tosoh
Wako
Zycare/Alere
Segment by Type
Chlamydia Testing
Syphilis Testing
Gonorrhea Testing
Herpes Simplex Virus Testing
Human Papilloma Virus Testing
Human Immunodeficiency Virus Testing
Chancroid Testing
Segment by Application
Laboratory Testing
Point of Care Testing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of STD Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global STD Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chlamydia Testing
1.2.3 Syphilis Testing
1.2.4 Gonorrhea Testing
1.2.5 Herpes Simplex Virus Testing
1.2.6 Human Papilloma Virus Testing
1.2.7 Human Immunodeficiency Virus Testing
1.2.8 Chancroid Testing
1.3 Market by Application
1.3.1 Global STD Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Laboratory Testing
1.3.3 Point of Care Testing
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global STD Diagnostics Market Perspective (2019-2030)
2.2 STD Diagnostics Growth Trends by Region
2.2.1 Global STD Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 STD Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 STD Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 STD Diagnostics Market Dynamics
2.3.1 STD Diagnostics Industry Trends
2.3.2 STD Diagnostics Market Drivers
2.3.3 STD Diagnostics Market Challenges
2.3.4 STD Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top STD Diagnostics Players by Revenue
3.1.1 Global Top STD Diagnostics Players by Revenue (2019-2024)
3.1.2 Global STD Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global STD Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by STD Diagnostics Revenue
3.4 Global STD Diagnostics Market Concentration Ratio
3.4.1 Global STD Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by STD Diagnostics Revenue in 2023
3.5 STD Diagnostics Key Players Head office and Area Served
3.6 Key Players STD Diagnostics Product Solution and Service
3.7 Date of Enter into STD Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 STD Diagnostics Breakdown Data by Type
4.1 Global STD Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global STD Diagnostics Forecasted Market Size by Type (2025-2030)
5 STD Diagnostics Breakdown Data by Application
5.1 Global STD Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global STD Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America STD Diagnostics Market Size (2019-2030)
6.2 North America STD Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America STD Diagnostics Market Size by Country (2019-2024)
6.4 North America STD Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe STD Diagnostics Market Size (2019-2030)
7.2 Europe STD Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe STD Diagnostics Market Size by Country (2019-2024)
7.4 Europe STD Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific STD Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific STD Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific STD Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific STD Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America STD Diagnostics Market Size (2019-2030)
9.2 Latin America STD Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America STD Diagnostics Market Size by Country (2019-2024)
9.4 Latin America STD Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa STD Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa STD Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa STD Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa STD Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott STD Diagnostics Introduction
11.1.4 Abbott Revenue in STD Diagnostics Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 ADI/American Diagnostica
11.2.1 ADI/American Diagnostica Company Detail
11.2.2 ADI/American Diagnostica Business Overview
11.2.3 ADI/American Diagnostica STD Diagnostics Introduction
11.2.4 ADI/American Diagnostica Revenue in STD Diagnostics Business (2019-2024)
11.2.5 ADI/American Diagnostica Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies STD Diagnostics Introduction
11.3.4 Agilent Technologies Revenue in STD Diagnostics Business (2019-2024)
11.3.5 Agilent Technologies Recent Development
11.4 Alere/Biosite/Inverness
11.4.1 Alere/Biosite/Inverness Company Detail
11.4.2 Alere/Biosite/Inverness Business Overview
11.4.3 Alere/Biosite/Inverness STD Diagnostics Introduction
11.4.4 Alere/Biosite/Inverness Revenue in STD Diagnostics Business (2019-2024)
11.4.5 Alere/Biosite/Inverness Recent Development
11.5 Axis-Shield
11.5.1 Axis-Shield Company Detail
11.5.2 Axis-Shield Business Overview
11.5.3 Axis-Shield STD Diagnostics Introduction
11.5.4 Axis-Shield Revenue in STD Diagnostics Business (2019-2024)
11.5.5 Axis-Shield Recent Development
11.6 Beckman Coulter/Danaher
11.6.1 Beckman Coulter/Danaher Company Detail
11.6.2 Beckman Coulter/Danaher Business Overview
11.6.3 Beckman Coulter/Danaher STD Diagnostics Introduction
11.6.4 Beckman Coulter/Danaher Revenue in STD Diagnostics Business (2019-2024)
11.6.5 Beckman Coulter/Danaher Recent Development
11.7 Becton Dickinson
11.7.1 Becton Dickinson Company Detail
11.7.2 Becton Dickinson Business Overview
11.7.3 Becton Dickinson STD Diagnostics Introduction
11.7.4 Becton Dickinson Revenue in STD Diagnostics Business (2019-2024)
11.7.5 Becton Dickinson Recent Development
11.8 Bio/Data
11.8.1 Bio/Data Company Detail
11.8.2 Bio/Data Business Overview
11.8.3 Bio/Data STD Diagnostics Introduction
11.8.4 Bio/Data Revenue in STD Diagnostics Business (2019-2024)
11.8.5 Bio/Data Recent Development
11.9 Decode Genetics
11.9.1 Decode Genetics Company Detail
11.9.2 Decode Genetics Business Overview
11.9.3 Decode Genetics STD Diagnostics Introduction
11.9.4 Decode Genetics Revenue in STD Diagnostics Business (2019-2024)
11.9.5 Decode Genetics Recent Development
11.10 Diadexus
11.10.1 Diadexus Company Detail
11.10.2 Diadexus Business Overview
11.10.3 Diadexus STD Diagnostics Introduction
11.10.4 Diadexus Revenue in STD Diagnostics Business (2019-2024)
11.10.5 Diadexus Recent Development
11.11 Diagnocure
11.11.1 Diagnocure Company Detail
11.11.2 Diagnocure Business Overview
11.11.3 Diagnocure STD Diagnostics Introduction
11.11.4 Diagnocure Revenue in STD Diagnostics Business (2019-2024)
11.11.5 Diagnocure Recent Development
11.12 Diagnostica Stago/Trinity Biotech
11.12.1 Diagnostica Stago/Trinity Biotech Company Detail
11.12.2 Diagnostica Stago/Trinity Biotech Business Overview
11.12.3 Diagnostica Stago/Trinity Biotech STD Diagnostics Introduction
11.12.4 Diagnostica Stago/Trinity Biotech Revenue in STD Diagnostics Business (2019-2024)
11.12.5 Diagnostica Stago/Trinity Biotech Recent Development
11.13 Diamedix
11.13.1 Diamedix Company Detail
11.13.2 Diamedix Business Overview
11.13.3 Diamedix STD Diagnostics Introduction
11.13.4 Diamedix Revenue in STD Diagnostics Business (2019-2024)
11.13.5 Diamedix Recent Development
11.14 Polymedco
11.14.1 Polymedco Company Detail
11.14.2 Polymedco Business Overview
11.14.3 Polymedco STD Diagnostics Introduction
11.14.4 Polymedco Revenue in STD Diagnostics Business (2019-2024)
11.14.5 Polymedco Recent Development
11.15 Qiagen
11.15.1 Qiagen Company Detail
11.15.2 Qiagen Business Overview
11.15.3 Qiagen STD Diagnostics Introduction
11.15.4 Qiagen Revenue in STD Diagnostics Business (2019-2024)
11.15.5 Qiagen Recent Development
11.16 Roche
11.16.1 Roche Company Detail
11.16.2 Roche Business Overview
11.16.3 Roche STD Diagnostics Introduction
11.16.4 Roche Revenue in STD Diagnostics Business (2019-2024)
11.16.5 Roche Recent Development
11.17 SDIX
11.17.1 SDIX Company Detail
11.17.2 SDIX Business Overview
11.17.3 SDIX STD Diagnostics Introduction
11.17.4 SDIX Revenue in STD Diagnostics Business (2019-2024)
11.17.5 SDIX Recent Development
11.18 Sequenom
11.18.1 Sequenom Company Detail
11.18.2 Sequenom Business Overview
11.18.3 Sequenom STD Diagnostics Introduction
11.18.4 Sequenom Revenue in STD Diagnostics Business (2019-2024)
11.18.5 Sequenom Recent Development
11.19 Siemens
11.19.1 Siemens Company Detail
11.19.2 Siemens Business Overview
11.19.3 Siemens STD Diagnostics Introduction
11.19.4 Siemens Revenue in STD Diagnostics Business (2019-2024)
11.19.5 Siemens Recent Development
11.20 Sienco
11.20.1 Sienco Company Detail
11.20.2 Sienco Business Overview
11.20.3 Sienco STD Diagnostics Introduction
11.20.4 Sienco Revenue in STD Diagnostics Business (2019-2024)
11.20.5 Sienco Recent Development
11.21 Sysmex
11.21.1 Sysmex Company Detail
11.21.2 Sysmex Business Overview
11.21.3 Sysmex STD Diagnostics Introduction
11.21.4 Sysmex Revenue in STD Diagnostics Business (2019-2024)
11.21.5 Sysmex Recent Development
11.22 Takara Bio
11.22.1 Takara Bio Company Detail
11.22.2 Takara Bio Business Overview
11.22.3 Takara Bio STD Diagnostics Introduction
11.22.4 Takara Bio Revenue in STD Diagnostics Business (2019-2024)
11.22.5 Takara Bio Recent Development
11.23 ThermoFisher
11.23.1 ThermoFisher Company Detail
11.23.2 ThermoFisher Business Overview
11.23.3 ThermoFisher STD Diagnostics Introduction
11.23.4 ThermoFisher Revenue in STD Diagnostics Business (2019-2024)
11.23.5 ThermoFisher Recent Development
11.24 Tosoh
11.24.1 Tosoh Company Detail
11.24.2 Tosoh Business Overview
11.24.3 Tosoh STD Diagnostics Introduction
11.24.4 Tosoh Revenue in STD Diagnostics Business (2019-2024)
11.24.5 Tosoh Recent Development
11.25 Wako
11.25.1 Wako Company Detail
11.25.2 Wako Business Overview
11.25.3 Wako STD Diagnostics Introduction
11.25.4 Wako Revenue in STD Diagnostics Business (2019-2024)
11.25.5 Wako Recent Development
11.26 Zycare/Alere
11.26.1 Zycare/Alere Company Detail
11.26.2 Zycare/Alere Business Overview
11.26.3 Zycare/Alere STD Diagnostics Introduction
11.26.4 Zycare/Alere Revenue in STD Diagnostics Business (2019-2024)
11.26.5 Zycare/Alere Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global STD Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Chlamydia Testing
Table 3. Key Players of Syphilis Testing
Table 4. Key Players of Gonorrhea Testing
Table 5. Key Players of Herpes Simplex Virus Testing
Table 6. Key Players of Human Papilloma Virus Testing
Table 7. Key Players of Human Immunodeficiency Virus Testing
Table 8. Key Players of Chancroid Testing
Table 9. Global STD Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global STD Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global STD Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global STD Diagnostics Market Share by Region (2019-2024)
Table 13. Global STD Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global STD Diagnostics Market Share by Region (2025-2030)
Table 15. STD Diagnostics Market Trends
Table 16. STD Diagnostics Market Drivers
Table 17. STD Diagnostics Market Challenges
Table 18. STD Diagnostics Market Restraints
Table 19. Global STD Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global STD Diagnostics Market Share by Players (2019-2024)
Table 21. Global Top STD Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in STD Diagnostics as of 2023)
Table 22. Ranking of Global Top STD Diagnostics Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by STD Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players STD Diagnostics Product Solution and Service
Table 26. Date of Enter into STD Diagnostics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global STD Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global STD Diagnostics Revenue Market Share by Type (2019-2024)
Table 30. Global STD Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global STD Diagnostics Revenue Market Share by Type (2025-2030)
Table 32. Global STD Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global STD Diagnostics Revenue Market Share by Application (2019-2024)
Table 34. Global STD Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global STD Diagnostics Revenue Market Share by Application (2025-2030)
Table 36. North America STD Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America STD Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America STD Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe STD Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe STD Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe STD Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific STD Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific STD Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific STD Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America STD Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America STD Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America STD Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa STD Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa STD Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa STD Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 51. Abbott Company Detail
Table 52. Abbott Business Overview
Table 53. Abbott STD Diagnostics Product
Table 54. Abbott Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. ADI/American Diagnostica Company Detail
Table 57. ADI/American Diagnostica Business Overview
Table 58. ADI/American Diagnostica STD Diagnostics Product
Table 59. ADI/American Diagnostica Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 60. ADI/American Diagnostica Recent Development
Table 61. Agilent Technologies Company Detail
Table 62. Agilent Technologies Business Overview
Table 63. Agilent Technologies STD Diagnostics Product
Table 64. Agilent Technologies Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 65. Agilent Technologies Recent Development
Table 66. Alere/Biosite/Inverness Company Detail
Table 67. Alere/Biosite/Inverness Business Overview
Table 68. Alere/Biosite/Inverness STD Diagnostics Product
Table 69. Alere/Biosite/Inverness Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 70. Alere/Biosite/Inverness Recent Development
Table 71. Axis-Shield Company Detail
Table 72. Axis-Shield Business Overview
Table 73. Axis-Shield STD Diagnostics Product
Table 74. Axis-Shield Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 75. Axis-Shield Recent Development
Table 76. Beckman Coulter/Danaher Company Detail
Table 77. Beckman Coulter/Danaher Business Overview
Table 78. Beckman Coulter/Danaher STD Diagnostics Product
Table 79. Beckman Coulter/Danaher Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 80. Beckman Coulter/Danaher Recent Development
Table 81. Becton Dickinson Company Detail
Table 82. Becton Dickinson Business Overview
Table 83. Becton Dickinson STD Diagnostics Product
Table 84. Becton Dickinson Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 85. Becton Dickinson Recent Development
Table 86. Bio/Data Company Detail
Table 87. Bio/Data Business Overview
Table 88. Bio/Data STD Diagnostics Product
Table 89. Bio/Data Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 90. Bio/Data Recent Development
Table 91. Decode Genetics Company Detail
Table 92. Decode Genetics Business Overview
Table 93. Decode Genetics STD Diagnostics Product
Table 94. Decode Genetics Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 95. Decode Genetics Recent Development
Table 96. Diadexus Company Detail
Table 97. Diadexus Business Overview
Table 98. Diadexus STD Diagnostics Product
Table 99. Diadexus Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 100. Diadexus Recent Development
Table 101. Diagnocure Company Detail
Table 102. Diagnocure Business Overview
Table 103. Diagnocure STD Diagnostics Product
Table 104. Diagnocure Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 105. Diagnocure Recent Development
Table 106. Diagnostica Stago/Trinity Biotech Company Detail
Table 107. Diagnostica Stago/Trinity Biotech Business Overview
Table 108. Diagnostica Stago/Trinity Biotech STD Diagnostics Product
Table 109. Diagnostica Stago/Trinity Biotech Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 110. Diagnostica Stago/Trinity Biotech Recent Development
Table 111. Diamedix Company Detail
Table 112. Diamedix Business Overview
Table 113. Diamedix STD Diagnostics Product
Table 114. Diamedix Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 115. Diamedix Recent Development
Table 116. Polymedco Company Detail
Table 117. Polymedco Business Overview
Table 118. Polymedco STD Diagnostics Product
Table 119. Polymedco Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 120. Polymedco Recent Development
Table 121. Qiagen Company Detail
Table 122. Qiagen Business Overview
Table 123. Qiagen STD Diagnostics Product
Table 124. Qiagen Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 125. Qiagen Recent Development
Table 126. Roche Company Detail
Table 127. Roche Business Overview
Table 128. Roche STD Diagnostics Product
Table 129. Roche Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 130. Roche Recent Development
Table 131. SDIX Company Detail
Table 132. SDIX Business Overview
Table 133. SDIX STD Diagnostics Product
Table 134. SDIX Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 135. SDIX Recent Development
Table 136. Sequenom Company Detail
Table 137. Sequenom Business Overview
Table 138. Sequenom STD Diagnostics Product
Table 139. Sequenom Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 140. Sequenom Recent Development
Table 141. Siemens Company Detail
Table 142. Siemens Business Overview
Table 143. Siemens STD Diagnostics Product
Table 144. Siemens Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 145. Siemens Recent Development
Table 146. Sienco Company Detail
Table 147. Sienco Business Overview
Table 148. Sienco STD Diagnostics Product
Table 149. Sienco Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 150. Sienco Recent Development
Table 151. Sysmex Company Detail
Table 152. Sysmex Business Overview
Table 153. Sysmex STD Diagnostics Product
Table 154. Sysmex Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 155. Sysmex Recent Development
Table 156. Takara Bio Company Detail
Table 157. Takara Bio Business Overview
Table 158. Takara Bio STD Diagnostics Product
Table 159. Takara Bio Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 160. Takara Bio Recent Development
Table 161. ThermoFisher Company Detail
Table 162. ThermoFisher Business Overview
Table 163. ThermoFisher STD Diagnostics Product
Table 164. ThermoFisher Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 165. ThermoFisher Recent Development
Table 166. Tosoh Company Detail
Table 167. Tosoh Business Overview
Table 168. Tosoh STD Diagnostics Product
Table 169. Tosoh Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 170. Tosoh Recent Development
Table 171. Wako Company Detail
Table 172. Wako Business Overview
Table 173. Wako STD Diagnostics Product
Table 174. Wako Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 175. Wako Recent Development
Table 176. Zycare/Alere Company Detail
Table 177. Zycare/Alere Business Overview
Table 178. Zycare/Alere STD Diagnostics Product
Table 179. Zycare/Alere Revenue in STD Diagnostics Business (2019-2024) & (US$ Million)
Table 180. Zycare/Alere Recent Development
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Global STD Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global STD Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Chlamydia Testing Features
Figure 4. Syphilis Testing Features
Figure 5. Gonorrhea Testing Features
Figure 6. Herpes Simplex Virus Testing Features
Figure 7. Human Papilloma Virus Testing Features
Figure 8. Human Immunodeficiency Virus Testing Features
Figure 9. Chancroid Testing Features
Figure 10. Global STD Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global STD Diagnostics Market Share by Application: 2023 VS 2030
Figure 12. Laboratory Testing Case Studies
Figure 13. Point of Care Testing Case Studies
Figure 14. STD Diagnostics Report Years Considered
Figure 15. Global STD Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global STD Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global STD Diagnostics Market Share by Region: 2023 VS 2030
Figure 18. Global STD Diagnostics Market Share by Players in 2023
Figure 19. Global Top STD Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in STD Diagnostics as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by STD Diagnostics Revenue in 2023
Figure 21. North America STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America STD Diagnostics Market Share by Country (2019-2030)
Figure 23. United States STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe STD Diagnostics Market Share by Country (2019-2030)
Figure 27. Germany STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific STD Diagnostics Market Share by Region (2019-2030)
Figure 35. China STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America STD Diagnostics Market Share by Country (2019-2030)
Figure 43. Mexico STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa STD Diagnostics Market Share by Country (2019-2030)
Figure 47. Turkey STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia STD Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Abbott Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 50. ADI/American Diagnostica Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 51. Agilent Technologies Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 52. Alere/Biosite/Inverness Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 53. Axis-Shield Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 54. Beckman Coulter/Danaher Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 55. Becton Dickinson Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 56. Bio/Data Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 57. Decode Genetics Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 58. Diadexus Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 59. Diagnocure Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 60. Diagnostica Stago/Trinity Biotech Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 61. Diamedix Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 62. Polymedco Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 63. Qiagen Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 64. Roche Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 65. SDIX Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 66. Sequenom Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 67. Siemens Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 68. Sienco Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 69. Sysmex Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 70. Takara Bio Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 71. ThermoFisher Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 72. Tosoh Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 73. Wako Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 74. Zycare/Alere Revenue Growth Rate in STD Diagnostics Business (2019-2024)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock